Minnesota HF 4: Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; civil penalties imposed; and money appropriated.

Status: Committee report, without further rec to amend, re-refer to Ways and Means (as of 2020-03-26)

State: Minnesota · Session: 2019-2020 · Bill: HF 4

Subjects: Drugs and Medicine, Health and Health Department

Sponsors: Lesch, Acomb, Bahner, Cantrell, Carlson, A., Claflin, Ecklund, Gomez, Hausman, Her, Hortman, Howard, Huot, Klevorn, Kunesh-Podein, Lee, Liebling, Lillie, Lislegard, Long, Mariani, Moran, Morrison, Noor, Olson

View Minnesota HF 4 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.